A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
about
Corticosteroid implants for chronic non-infectious uveitisOcular Complications of Diabetes and Therapeutic ApproachesIntraocular Implants for the Treatment of Autoimmune UveitisManagement of noninfectious posterior uveitis with intravitreal drug therapyMoving Past Anti-VEGF: Novel Therapies for Treating Diabetic RetinopathyReview of Systemic Immunosuppression for Autoimmune UveitisImpact on intraocular pressure after 20-mg decanted triamcinolone acetonide (kenalog) injection when using prophylactic antiglaucoma therapy.Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant.Controlled Release of Dexamethasone From an Intravitreal Delivery System Using Porous Silicon Dioxide.Uveitic Macular Edema: Treatment Update.New options for uveitis treatment.Pediatric uveitis: new and future treatments.The Sustained-Release Dexamethasone Implant: Expanding Indications in Vitreoretinal Disease.A comprehensive review and update on the non-biologic treatment of adult noninfectious uveitis: part I.Sustained-release fluocinolone acetonide intravitreal insert for macular edema: clinical pharmacology and safety evaluation.Nonbiological pharmacotherapies for the treatment of diabetic macular edema.Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy.Treatment of Non-infectious Uveitic Macular Edema with the Intravitreal Dexamethasone Implant.Dexamethasone intravitreal implant (Ozurdex®) for pediatric uveitis.Clinical Considerations for Vascularized Composite Allotransplantation of the Eye.Dexamethasone implants in paediatric patients with noninfectious intermediate or posterior uveitis: first prospective exploratory case series.Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone.Intravitreal Adalimumab for the Control of Breakthrough Intraocular Inflammation.Protective coatings for intraocular wirelessly controlled microrobots for implantation: Corrosion, cell culture, and in vivo animal tests.Clinical Outcomes of Intravitreal Preservative-Free Triamcinolone Preparation (Triesence®) for Cystoid Macular Oedema and Inflammation in Patients with Uveitis.[Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for intravitreal treatment of macular edema in uveitis: Date: 02/07/2014].Ahmed glaucoma valve in uveitic patients with fluocinolone acetonide implant-induced glaucoma: 3-year follow-up.Intravitreal therapeutic agents in noninfectious uveitic macular edema
P2860
Q24186144-72459381-3CF1-4AC1-99D4-73652410C2FFQ26749412-4DA0EDB8-C46A-477D-95B2-EF0A73209088Q26799168-C88821BB-F6BB-4D43-A7E0-736E91C8EDEEQ28074741-AA434B9E-2F94-43B3-81EC-4819C31D8A5EQ28078199-FF2C33AE-1466-4F37-B0C6-86563E20FE87Q34627012-136339D8-50B8-45B9-87B1-EA78EC41F1F8Q34771834-CAA1BA34-AF01-4E23-87F4-F3A838FC2107Q35128723-748EA5C0-E191-47A9-A65E-DDBA90CDB730Q36592576-FEF66FF4-1EFD-46A1-85BE-5485F388B227Q37029324-8AD1B981-92F7-4E22-A6C6-51FC56FE1D6FQ37256887-E124B136-95CB-4908-A91B-AAD5F6ECD982Q38123032-FFFA3EE7-4BDE-4A6C-9E11-6D78CD98ED2DQ38198098-372CB489-21D4-4BA9-B57D-4DD6F3A7C298Q38250116-CFAA4369-B4BF-4808-89A1-F4018335489CQ38494605-65DC2DFB-0FBE-412D-A082-764D7526B690Q38622256-31FDAEDA-7430-422E-B7C3-6371FFE41C3BQ39679791-FEAE325D-80BA-4772-ACAB-072C8DD0A59BQ39898518-2A072B49-DC53-4B3F-8A02-D923727B5BD0Q40675700-E09826AD-774E-4139-B933-5261756625C9Q41647397-64AF38D1-C481-43D0-986D-18609B454193Q47143608-E40EA6C4-C9FE-4362-AC1D-99B607BD0E43Q47145465-949F5072-B2A1-42BB-A501-4CBA1A04FB05Q50091416-C9508FDF-8CCD-4E18-BFE9-021A60FA2180Q50727947-C5467A69-B14F-4B18-A758-CE52610BD0C5Q50789266-7EA20D7B-9771-4125-9862-AF02B41C267FQ54641208-03004B72-F24E-446B-9A67-53AE9C7C143BQ55007876-BE07ABB5-AD35-4120-8785-B06866D20C01Q58806282-D2D9B2E9-7A71-408F-95DE-49D4ABBFD422
P2860
A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A comparison between the fluoc ...... ravitreal implants in uveitis.
@ast
A comparison between the fluoc ...... ravitreal implants in uveitis.
@en
A comparison between the fluocinolone acetonide
@nl
type
label
A comparison between the fluoc ...... ravitreal implants in uveitis.
@ast
A comparison between the fluoc ...... ravitreal implants in uveitis.
@en
A comparison between the fluocinolone acetonide
@nl
prefLabel
A comparison between the fluoc ...... ravitreal implants in uveitis.
@ast
A comparison between the fluoc ...... ravitreal implants in uveitis.
@en
A comparison between the fluocinolone acetonide
@nl
P2093
P356
P1476
A comparison between the fluoc ...... ravitreal implants in uveitis.
@en
P2093
C Stephen Foster
Cheryl A Arcinue
Olga M Cerón
P304
P356
10.1089/JOP.2012.0180
P577
2013-01-08T00:00:00Z